Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development

BACKGROUND: mRNA vaccines are a novel technology that provide a potential strategy for cancer treatment. However, few studies exist that are focused on the application and development of mRNA vaccines in bladder cancer (BLCA). Therefore, this study filtered candidate antigens and specific mRNA-suita...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guixin, Gao, Yukui, Chen, Yanzhuo, Wang, Keruo, Zhang, Shicheng, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263198/
https://www.ncbi.nlm.nih.gov/pubmed/35814377
http://dx.doi.org/10.3389/fonc.2022.921711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263198/
https://www.ncbi.nlm.nih.gov/pubmed/35814377
http://dx.doi.org/10.3389/fonc.2022.921711

Ejemplares similares